Kano Therapeutics

Kano Therapeutics is a biotechnology startup focused on developing next-generation genetic medicine using a novel form of DNA called circular single-stranded DNA (cssDNA). Founded in 2021 as a spinout from MIT, the company is based in Cambridge, Massachusetts and operates at the intersection of synthetic biology, gene therapy, and genome engineerin... g. Its core mission is to make gene and cell therapies safer, more efficient, and more widely accessible by improving the fundamental payload used to deliver genetic instructions into cells. Unlike conventional approaches that rely on viral vectors or double-stranded DNAwhich can trigger immune responses or have limitations in deliveryKano Therapeutics designs engineered cssDNA molecules that are more stable, less immunogenic, and easier to manufacture at scale. This circular DNA structure can be customized in length and sequence, enabling precise gene insertion and editing for a variety of therapeutic applications, including cancer treatment, genetic disease correction, and cell therapy development. The company also integrates manufacturing, computational design, and screening into a unified platform, aiming to streamline the development of gene therapies from research to clinical use. By using fermentation-based production methods, it seeks to reduce cost and improve scalability compared to traditional chemical DNA synthesis.Read More